Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteedisonpharma.com/...
Twitter@edisonpharma
CategoryBioTech
Emailcompany@edisonpha...
Employees
Founded2005

Offices

Mountain View, USA
350 North Bernardo Avenue
Mountain View, CA, 94043
USA

People

Vice President,Pharmaceutical Development and Manufacturing
Vice President of Quality Assurance
Vice President, R&D Operations/Alliance Management
Chairman & CEO
Chief Medical Officer
Chief Drug Development Officer
Executive Vice President, Commercial Operations
Senior Vice President of Innovation

Funding

TOTAL $80.1M
FUNDING TOTAL $80.1M
Partial Close, 4/2009
$2.75M
Partial Close, 4/2010
$3.02M
Partial Close, 8/2010
$250k
Series E, 1/2012
$4.1M
Series F, 11/2012
Mitsui Global Investment
$20M
Private Equity, 3/2014
Dainippon Sumitomo
$50M

Tags

Edison Pharmaceuticals

Edison Pharmaceuticals is a patient- and physician-founded company devoted to developing new medicines to transform the lives of children and adults diagnosed with rare and neglected diseases. Currently, the company is focused on inherited mitochondrial diseases for which there are no approved drugs. These conditions are life-threatening and highly debilitating. Edison’s specialized skill set spans the discovery, development, and translation of redox-based drugs.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Edison Pharmaceuticals, Inc.: Series E $4.1M (onbiovc.com) [edit]
  5. Edison Pharmaceuticals Closes $20M Series F Financing (finsmes.com) [edit]
  6. Edison Pharmaceuticals, Inc. enters into strategic alliance with Dainippon Sumitomo Pharma Co., Ltd. (prnewswire.com) [edit]
Edit This Page
Last Edited 3/31/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy